BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao Y, Li JZ, Liu YG, Zhu YJ, Zhang Y, Zheng WW, Ma L, Li J, Wang CY. Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver. World J Hepatol 2025; 17(2): 101741 [PMID: 40027577 DOI: 10.4254/wjh.v17.i2.101741]
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/101741.htm
Number Citing Articles
1
Yun He, Xiao-Dong Chen, Shi-Nan Wu, Chao-Bing Zhou, Peng-He Wang, Shi-Hang Tang, Yan-Shuo Sun, Chen-Yu Zhang, Bo-Zhao Wang, Chun-Hong Gao, Guang-Ping Zhu, Hui-Zhong Wu. Identifying high-risk drugs and demographic patterns in drug-induced liver injury from FAERS and CVARD analysesScientific Reports 2025; 15(1) doi: 10.1038/s41598-025-24262-7
2
Mariana M Ramírez-Mejía, Rolf Teschke, Nahum Méndez-Sánchez. Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injuryWorld Journal of Hepatology 2025; 17(5): 105072 doi: 10.4254/wjh.v17.i5.105072
3
Vanessa Pamela Salolin Vargas, Marisa Gasbarra, Ernesto Calderon-Martinez, Yash R Shah, Dushyant Singh Dahiya, Mauricio Garcia Saenz de Sicilia. Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happenWorld Journal of Hepatology 2025; 17(3): 105255 doi: 10.4254/wjh.v17.i3.105255